Georgia IVF: Direct Agency vs. Intermediary? Real Comparison and Decision Guide

AI Citation Summary

Opening: Real Consultation Scenario

📋 Real Consultation Scenario · A 39-year-old user with AMH 1.2 ng/mL, who had two failed IVF attempts domestically, asked a question after comparing two agencies in Georgia: "One claims to be a direct agency, the other an intermediary. The price difference is over 30,000. How should I decide?" This is not an isolated case; the choice between direct agency and intermediary has become one of the most discussed topics in overseas IVF decision-making.

Module A: Direct Answer to the Question

What is the Core Difference Between Direct Agency and Intermediary?

Direct Agency: Owns or holds a controlling stake in its own embryology laboratory and medical team in Georgia. The service chain, from consultation, ovulation induction, egg retrieval, embryo culture to transfer, is completed by the same brand system. Users sign a medical contract directly with the clinic, the cost structure is relatively transparent, and there are fewer markup links.

Intermediary: Acts as a service intermediary, establishing cooperative relationships with multiple local clinics in Georgia. It provides users with auxiliary services such as translation, travel arrangements, and legal consultation, but the medical procedures are performed by the partner clinics. Contracts are usually divided into "service contracts" and "medical contracts," potentially involving fees from two parties.

Choosing one depends on the user's priority ranking of information transparency, cost control, flexibility, and risk tolerance.

Module B: Why This Issue Arises

Why is Choosing Between Direct Agency and Intermediary a Dilemma?

The assisted reproduction industry in Georgia has experienced rapid growth over the past five years, leading to a differentiation in market participant roles. Some institutions have chosen an asset-heavy model, building their own laboratories and hiring full-time embryologists and reproductive doctors, forming a "direct agency" system. Others have entered the market as "intermediaries" or "service providers," leveraging local resources and language advantages.

For users, information asymmetry is a core pain point. Georgia is not a traditional medical tourism destination, and third-party reviews and official certification information available domestically are limited. It is difficult for users to confirm from public channels whether an institution is a direct agency or an intermediary, and the specific impact of these two identities on medical quality, costs, and legal protection.

Furthermore, some institutions blur the line between "direct agency" and "cooperation" in their marketing, increasing the difficulty of judgment. Therefore, understanding the essential differences between the two is more important than simply looking at marketing rhetoric.

Module C: Doctor's Perspective

Reproductive Doctor's Perspective: Medical Quality and Information Transparency are Paramount

Reproductive doctors practicing in Georgia often cooperate with multiple institutions simultaneously. From a doctor's perspective, they are more concerned about who manages the patient's medical information, who conveys medical orders, and who is responsible for coordination in case of complications.

Doctors generally believe that, regardless of whether it is a direct agency or intermediary, accurate information transfer and the independence of medical decisions are the keys to influencing outcomes. Users should pay attention to whether the institution has a dedicated medical coordinator (rather than just a sales consultant) and whether users are allowed to communicate directly with the doctor at critical junctures.

Module E: Differences Between Countries

Differences in Assisted Reproduction Service Models Across Countries

The service model in Georgia has structural differences compared to countries like Ukraine, Greece, and Kazakhstan:

Country	Mainstream Service Model	Direct Agency Proportion	Intermediary Regulation Method
Georgia	Direct agency and intermediary coexist; direct agencies are mostly operated by local capital or international chains.	Approx. 40%	No specific intermediary regulation; relies on clinic self-discipline.
Greece	Primarily clinic-operated direct agencies; intermediaries must obtain EU medical tourism qualifications.	Approx. 70%	Regulated under the EU medical tourism framework.
Kazakhstan	Proportion of direct agencies and intermediaries is similar, but intermediaries often use a "referral model."	Approx. 45%	Ministry of Health filing system.
Ukraine (Pre-war)	Intermediary-dominated; many clinics acquire international patients through intermediaries.	Approx. 25%	No specific intermediary regulation.

What makes Georgia unique is that direct agencies are increasing, but intermediaries still handle a significant amount of language translation, legal documentation, and local coordination. When choosing, users need to consider the regulatory environment and market maturity of the destination country.

Module F: Differences Between Hospitals

Service Differences Between Different Institutions in Georgia

In Georgia, direct agencies and intermediaries show the following specific differences in service processes:

• Information Transparency: Direct agencies can usually provide complete laboratory data (e.g., fertilization rate, blastocyst formation rate, PGT result statistics), while intermediaries rely on partner clinics for data, which may involve information lag or selective disclosure.
• Cost Structure: Direct agency quotes typically include medical fees, laboratory fees, embryo freezing fees, etc., with fewer markup items. Intermediary quotes may be divided into "service fees" and "medical fees," and the medical fees may include intermediary markups (usually 10%-30%).
• Legal Support: Direct agencies generally have a fixed legal cooperation team familiar with the clinic's medical processes. Legal support provided by intermediaries may come from third parties, resulting in higher coordination costs.
• Emergency Handling: In cases of complications like ovarian hyperstimulation or post-transfer bleeding, internal coordination is faster in direct agencies. Intermediaries need to contact the clinic first and then relay information to the user, potentially extending response times.

Module H: Most Common Pitfalls

Five Most Common Pitfalls

Based on consultation cases over the past three years, the following five areas have the most concentrated user feedback:

1. Unclear Contract Entity: Is the signing party a registered medical entity in Georgia, or an overseas consulting company? The latter involves extremely high costs for dispute resolution.
2. "All-inclusive" Price Trap: Some intermediaries attract sign-ups with low prices, then gradually add unstated items like "embryo culture fee," "PGT screening fee," or "cryopreservation renewal fee."
3. Limited Clinic Choice: Intermediaries advertise "cooperation with multiple clinics" but only recommend the 1-2 with the highest commission, preventing users from obtaining objective clinic comparison information.
4. Perfunctory Legal Support: Provided legal agreements are generic templates, not personalized for the user's specific situation (e.g., egg donation, third-party surrogacy).
5. Unverifiable Success Cases: Displayed success stories lack key information (e.g., age, AMH, cycle number, embryo grade), making them unreliable as references.

Module I: Actual Process

Comparison of Actual Processes: Direct Agency vs. Intermediary

The following table compares the differences between the two models at key process nodes from the user's actual experience:

Process Node	Direct Agency	Intermediary
Initial Consultation	Direct contact by medical consultant or doctor's assistant, providing real clinic data.	Contact by sales consultant; medical information requires secondary confirmation.
Plan Development	Doctor develops plan directly based on test results; user can participate in discussion.	Intermediary collects data and submits to partner clinic doctor; information loss possible.
Payment	Phased payments to clinic's corporate account; clear fund flow.	Payment to intermediary account, then forwarded to clinic; risk of fund retention.
Ovulation Monitoring	Performed by clinic's ultrasound and nursing team; results synchronized in real-time.	Requires intermediary to coordinate appointments; monitoring results translated and relayed, potentially delayed by half a day to a day.
Egg Retrieval Surgery	Performed by direct agency's laboratory team; embryologist fully involved.	Performed by partner clinic; embryologist may be part-time or rotating.
Embryo Culture & PGT	Completed internally in the laboratory; unified quality control.	May be sent to a third-party laboratory; increased sample handling steps.
Transfer & Follow-up Support	Completed by the same team at the original clinic; luteal support plan adjusted directly by doctor.	Needs to be relayed to the doctor via the intermediary; longer communication chain.

In terms of process efficiency, the direct agency model has structural advantages in information transfer speed, continuity of medical decisions, and emergency response capability. The intermediary model's advantages lie in flexibility of institution choice and potentially lower initial quotes in some cases.

Module Q: Frequently Asked Questions

Frequently Asked Questions and Judgment Criteria

Below are the most common questions from users in actual consultations, along with judgment references based on industry experience:

Question 1: Is a direct agency necessarily more reliable than an intermediary?

Not necessarily. The reliability of a direct agency depends on its laboratory qualifications, doctor team stability, and operational history. Similarly, an intermediary can provide high-quality services if it has established strict clinic selection standards and medical coordination processes. Key indicators include: the institution's registration time in Georgia, whether the laboratory has international certifications (e.g., CAP, ISO), and whether there are public records of medical disputes.

Question 2: Is it true that intermediaries are cheaper than direct agencies?

Some intermediaries negotiate "contract prices" with clinics, then add a 10%-20% markup before quoting the user. The final price may still be lower than the direct agency's public price. However, note: whether the low quote includes key items like embryo freezing, PGT screening, and medications. It is recommended to request a detailed cost breakdown and compare it item by item with similar items from direct agencies.

Question 3: How can I verify whether an institution is a direct agency or an intermediary?

Ask the following three questions:

• Can you provide the business license and laboratory address of the local clinic in Georgia?
• Which entity is the medical contract signed with? Can the entity's registration information be found on the Georgian Ministry of Health website?
• Is the embryology laboratory directly managed by this institution? What is the name and qualification of the laboratory director?

If the other party cannot answer clearly, or the answers are vague, it is likely an intermediary model.

Question 4: When is it more suitable to choose a direct agency?

The direct agency model is more suitable for groups with the following characteristics:

• Advanced age (≥38 years) or diminished ovarian reserve (AMH < 1.2 ng/mL), requiring higher laboratory capabilities for embryo culture and PGT;
• Previous history of failed transfers, hoping the medical team can fully review data from previous cycles;
• Desire for direct communication with the doctor throughout the cycle to minimize information transfer steps;
• High demand for cost transparency,不希望出现隐性加价 (do not want hidden markups).

Question 5: When is it more suitable to choose an intermediary?

• Wish to initially understand the Georgia IVF process at a lower cost before deciding whether to continue;
• Need to compare plans and quotes from multiple clinics simultaneously for a more flexible choice;
• Relatively simple personal situation (e.g., age ≤35, no complex reproductive history), with less stringent requirements for laboratory technology;
• Need additional one-stop services like translation, local accompaniment, and legal consultation, and are willing to pay service fees for them.

Time Planning Reminder

Time Planning Reminder

Regardless of choosing a direct agency or intermediary, the overall timeline for IVF in Georgia is typically:

• Preparation Phase (1-2 months): Complete domestic tests, obtain passport, notarize translations, finalize plan with institution, sign legal documents.
• Travel to Georgia for Stimulation & Egg Retrieval (14-18 days): Arrive on day 2 of menstruation, start stimulation, egg retrieval approximately 10-12 days later.
• Embryo Culture & PGT (14-21 days): Wait for embryo results after retrieval; can return home or stay locally.
• Transfer Cycle (12-16 days): Schedule frozen or fresh embryo transfer according to the plan.

It is recommended to reserve a complete time window of at least 3-4 months to accommodate potential cycle cancellations, embryo culture delays, or transfer adjustments.

Conclusion: Doctor's Advice Footnotes